Nordic Pharmacovigilance Day

It is our pleasure to announce that the well-known Nordic Pharmacovigilance Day conference is taking place on 13 November 2024, in Copenhagen, Denmark. The conference offers a full day of engagement for professionals deeply involved in pharmacovigilance and related activities, as well as being a valuable platform to delve into current and compelling topics including fostering collaboration across various departments and companies.

The primary objective of the conference is to provide delegates with a friendly environment for learning, interaction, active participation, and inspiration. Given the rapidly evolving expectations in pharmacovigilance across diverse areas, the conference agenda will encompass multiple perspectives. This includes viewpoints from regulators, insights from partners and service providers, and case studies from both small and large pharmaceutical companies.

The program will be focused on concrete presentations, real life experiences and useful “take-home” messages, covering  “hot topics”, such as PV oversight, digital media listening, implementation of RMP and RMM, signal analytical tools, combination products, PV system governance and responsibilities from both local and global point of views.

Looking forward to meeting you in Copenhagen for a wonderful day of sharing, training, and networking! See you there!

Scientific Board

• Wasim Anwar - Vice President & Deputy QPPV - Head of QPPV Office, Global Safety at Novo Nordisk A/S
• Caroline Susanne Sandström - Head of Global Clinical Quality at Ferring Pharmaceuticals A/S
• Mette Stie Kallesøe - Head of Pharmacovigilance, QPPV at Hansa Biopharma AB

Who should attend?
The conference program is designed for healthcare professionals or pharmacists working in the pharmacovigilance units in the pharmaceutical industry or regulatory agencies, either as specialists or managers, QPPVs, inspectors and QA personnel including auditors, employees in regulatory affairs units with close relations to pharmacovigilance, vendors and CROs working with patient safety data.